Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: Multicentre, prospective study
Oliver Stirrup, James Blackstone, Fiona Mapp, Alyson MacNeil, Monica Panca, Alison Holmes, Nicholas Machin, Gee Yen Shin, Tabitha Mahungu, Kordo Saeed, Tranprit Saluja, Yusri Taha, Nikunj Mahida, Cassie Pope, Anu Chawla, Maria-Teresa Cutino-Moguel, Asif Tamuri, Rachel Williams, Alistair Darby, David L Robertson, Flavia Flaviani, Eleni Nastouli, Samuel Robson, Darren Smith, Matthew Loose, Kenneth Laing, Irene Monahan, Beatrix Kele, Sam Haldenby, Ryan George, Matthew Bashton, Adam A Witney, Matthew Byott, Francesc Coll, Michael Chapman, Sharon J Peacock, COG-UK HOCI Investigators, COVID-19 Genomics UK (COG-UK) consortium, Joseph Hughes, Gaia Nebbia, David G Partridge, Matthew Parker, James Richard Price, Christine Peters, Sunando Roy, Luke B Snell, Thushan I de Silva, Emma Thomson, Paul Flowers, Andrew Copas, Judith Breuer, Oliver Stirrup, James Blackstone, Fiona Mapp, Alyson MacNeil, Monica Panca, Alison Holmes, Nicholas Machin, Gee Yen Shin, Tabitha Mahungu, Kordo Saeed, Tranprit Saluja, Yusri Taha, Nikunj Mahida, Cassie Pope, Anu Chawla, Maria-Teresa Cutino-Moguel, Asif Tamuri, Rachel Williams, Alistair Darby, David L Robertson, Flavia Flaviani, Eleni Nastouli, Samuel Robson, Darren Smith, Matthew Loose, Kenneth Laing, Irene Monahan, Beatrix Kele, Sam Haldenby, Ryan George, Matthew Bashton, Adam A Witney, Matthew Byott, Francesc Coll, Michael Chapman, Sharon J Peacock, COG-UK HOCI Investigators, COVID-19 Genomics UK (COG-UK) consortium, Joseph Hughes, Gaia Nebbia, David G Partridge, Matthew Parker, James Richard Price, Christine Peters, Sunando Roy, Luke B Snell, Thushan I de Silva, Emma Thomson, Paul Flowers, Andrew Copas, Judith Breuer
Abstract
Background: Viral sequencing of SARS-CoV-2 has been used for outbreak investigation, but there is limited evidence supporting routine use for infection prevention and control (IPC) within hospital settings.
Methods: We conducted a prospective non-randomised trial of sequencing at 14 acute UK hospital trusts. Sites each had a 4-week baseline data collection period, followed by intervention periods comprising 8 weeks of 'rapid' (<48 hr) and 4 weeks of 'longer-turnaround' (5-10 days) sequencing using a sequence reporting tool (SRT). Data were collected on all hospital-onset COVID-19 infections (HOCIs; detected ≥48 hr from admission). The impact of the sequencing intervention on IPC knowledge and actions, and on the incidence of probable/definite hospital-acquired infections (HAIs), was evaluated.
Results: A total of 2170 HOCI cases were recorded from October 2020 to April 2021, corresponding to a period of extreme strain on the health service, with sequence reports returned for 650/1320 (49.2%) during intervention phases. We did not detect a statistically significant change in weekly incidence of HAIs in longer-turnaround (incidence rate ratio 1.60, 95% CI 0.85-3.01; p=0.14) or rapid (0.85, 0.48-1.50; p=0.54) intervention phases compared to baseline phase. However, IPC practice was changed in 7.8 and 7.4% of all HOCI cases in rapid and longer-turnaround phases, respectively, and 17.2 and 11.6% of cases where the report was returned. In a 'per-protocol' sensitivity analysis, there was an impact on IPC actions in 20.7% of HOCI cases when the SRT report was returned within 5 days. Capacity to respond effectively to insights from sequencing was breached in most sites by the volume of cases and limited resources.
Conclusions: While we did not demonstrate a direct impact of sequencing on the incidence of nosocomial transmission, our results suggest that sequencing can inform IPC response to HOCIs, particularly when returned within 5 days.
Funding: COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) (grant code: MC_PC_19027), and Genome Research Limited, operating as the Wellcome Sanger Institute.
Clinical trial number: NCT04405934.
Keywords: COVID-19; epidemiology; global health; healthcare-associated infection; hospital-acquired infection; human; infection control; infection prevention; infectious disease; microbiology; molecular epidemiology; viral genomics.
Conflict of interest statement
OS, JB, FM, AM, MP, AH, NM, TM, KS, TS, YT, NM, CP, AC, AT, RW, AD, DR, FF, SR, ML, KL, IM, BK, SH, RG, MB, AW, MB, MC, JH, GN, DP, MP, JP, CP, SR, LS, Td, ET, AC, JB No competing interests declared, GS has an unpaid role as Deputy Chair, British Medical Association London Regional Council. The author has no other competing interests to declare, MC received payment for anonymous interview conducted by Adkins Research Group. The author has no other competing interests to declare, EN holds grants by NIHR, EPSRC, MRC-UKRI , H2020, ViiV Healthcare, Pfizer and Amfar, and has received grants to attend meetings from H2020 and ViiV Healthcare, DS holds the following grants that are not specifically for the present work: COG-UK, PHE test and trace funded the sequencing aspect. HOCI funded a technician to support sequencing during study period. The author has no other competing interests to declare, FC received consulting fees from Next Gen Diagnostics LLC (during 2018/2019), received payment or honoria for lectures from University of Cambridge and Wellcome Genome Campus Advanced Courses, and received support for attending meeting and/or travel to meetings from European Congress of Clinical Microbiology &amp; Infectious Diseases (ECCMID), The American Society for Microbiology (ASM), Microbiology Society, European Congress of Clinical Microbiology &amp; Infectious Diseases (ECCMID), and the British Infection Association (BIA). The author has no other competing interests to declare, SP received consultancy fees from Pfizer (Coronavirus External Advisory Board) and Melinta Therapeutics, received payment from SVB Leerink for a round table meeting and for Mary Strauss Distinguished Public Lecture from the Fralin Biomedical Research Institute, US, and support for attending ICPIC conference, Geneva and World Health Summit, Berlin in 2021, and hold stocks or stock options in Specific Technologies (European Union Scientific Advisory Board) and Next Gen Diagnostics (Scientific Advisory Board). SP also serves as Chair, Medical Advisory Committee, Sir Jules Thorn Charitable Trust, Board member of the Wellcome SEDRIC (Surveillance and Epidemiology of Drug Resistant Consortium), and Non-Executive Director of Cambridge University Hospitals NHS Foundation Trust. The author has no other competing interests to declare, PF is a member of the SAGE hospital onset covid working group 2020-2022. The author has no other competing interests to declare
© 2022, Stirrup et al.
Figures
References
- Abbas M, Robalo Nunes T, Martischang R, Zingg W, Iten A, Pittet D, Harbarth S. Nosocomial transmission and outbreaks of coronavirus disease 2019: the need to protect both patients and healthcare workers. Antimicrobial Resistance and Infection Control. 2021;10:7. doi: 10.1186/s13756-020-00875-7.
- Allen JG, Ibrahim AM. Indoor air changes and potential implications for SARS-cov-2 transmission. JAMA. 2021;325:2112–2113. doi: 10.1001/jama.2021.5053.
- Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, Gower C, Kall M, Groves N, O’Connell AM, Simons D, Blomquist PB, Zaidi A, Nash S, Iwani Binti Abdul Aziz N, Thelwall S, Dabrera G, Myers R, Amirthalingam G, Gharbia S, Barrett JC, Elson R, Ladhani SN, Ferguson N, Zambon M, Campbell CNJ, Brown K, Hopkins S, Chand M, Ramsay M, Lopez Bernal J. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant. The New England Journal of Medicine. 2022;386:1532–1546. doi: 10.1056/NEJMoa2119451.
- Bhattacharya A, Collin SM, Stimson J, Thelwall S, Nsonwu O, Gerver S, Robotham J, Wilcox M, Hopkins S, Hope R. Healthcare-Associated COVID-19 in England: a national data linkage study. The Journal of Infection. 2021;83:565–572. doi: 10.1016/j.jinf.2021.08.039.
- Blackstone J, Stirrup O, Mapp F, Panca M, Copas A, Flowers P, Hockey L, Price J, Partridge D, Peters C, de Silva T, Nebbia G, Snell LB, McComish R, Breuer J, COVID-19 Genomics UK Consortium Protocol for the COG-UK hospital-onset COVID-19 infection (HOCI) multicentre interventional clinical study: evaluating the efficacy of rapid genome sequencing of SARS-cov-2 in limiting the spread of COVID-19 in UK NHS hospitals. BMJ Open. 2022;12:e052514. doi: 10.1136/bmjopen-2021-052514.
- Blanquart F, Hozé N, Cowling BJ, Débarre F, Cauchemez S. Selection for infectivity profiles in slow and fast epidemics and the rise of SARS-cov-2 variants. eLife. 2022;11:e75791. doi: 10.7554/eLife.75791.
- Boshier FAT, Venturini C, Stirrup O, Guerra-Assunção JA, Alcolea-Medina A, Becket AH, Byott M, Charalampous T, Filipe ADS, Frampton D, Glaysher S, Khan T, Kulasegara-Shylini R, Kele B, Monahan IM, Mollett G, Parker M, Pelosi E, Randell P, Roy S, Taylor JF, Weller SJ, Wilson-Davies E, Wade P, Williams R, Copas AJ, Cutino-Moguel T, Freemantle N, Hayward AC, Holmes A, Hughes J, Mahungu TW, Nebbia G, Nastouli E, Partridge DG, Pope CF, Price JR, Robson SC, Saeed K, Shin GY, de Silva TI, Snell LB, Thomson EC, Witney AA, Breuer J, COG-UK HOCI Variant Substudy consortium, The COVID-19 Genomics UK consortium The alpha variant was not associated with excess nosocomial SARS-cov-2 infection in a multi-centre UK hospital study. The Journal of Infection. 2021;83:693–700. doi: 10.1016/j.jinf.2021.09.022.
- Brown JR, Roy S, Shah D, Williams CA, Williams R, Dunn H, Hartley J, Harris K, Breuer J. Norovirus transmission dynamics in a pediatric hospital using full genome sequences. Clinical Infectious Diseases. 2019;68:222–228. doi: 10.1093/cid/ciy438.
- Colton H, Parker MD, Stirrup O, Blackstone J, Loose M, McClure CP, Roy S, Williams C, McLeod J, Smith D, Taha Y, Zhang P, Hsu SN, Kele B, Harris K, Mapp F, Williams R, COG-UK HOCI Investigators, The COVID-19 Genomics UK (COG-UK) Consortium. Flowers P, Breuer J, Partridge DG, de Silva TI. Factors affecting turnaround time of SARS-cov-2 sequencing for inpatient infection prevention and control decision making: analysis of data from the COG-UK HOCI study. The Journal of Hospital Infection. 2022:S0195-6701(22)00318-8. doi: 10.1016/j.jhin.2022.09.022.
- Conway Morris A, Sharrocks K, Bousfield R, Kermack L, Maes M, Higginson E, Forrest S, Pereira-Dias J, Cormie C, Old T, Brooks S, Hamed I, Koenig A, Turner A, White P, Floto RA, Dougan G, Gkrania-Klotsas E, Gouliouris T, Baker S, Navapurkar V. The removal of airborne severe acute respiratory syndrome coronavirus 2 (SARS-cov-2) and other microbial bioaerosols by air filtration on coronavirus disease 2019 (COVID-19) surge units. Clinical Infectious Diseases. 2022;75:e97–e101. doi: 10.1093/cid/ciab933.
- Ferris M, Ferris R, Workman C, O’Connor E, Enoch DA, Goldesgeyme E. Efficacy of FFP3 respirators for prevention of SARS-cov-2 infection in healthcare workers. eLife. 2021;10:e71131. doi: 10.7554/eLife.71131.
- Flowers P, Mapp F, Blackstone J, Stirrup O, Breuer J. Developing Initial Programme Theory: COVID-19 Genomics UK Consortium Hospital-Onset COVID-19 Study (COG-UK HOCI) SocArXiv. 2021 doi: 10.31235/.
- Flowers P, McLeod J, Mapp F, Stirrup O, Blackstone J, Snell L. How Acceptable Is Rapid Whole Genome Sequencing for Infectious Disease Management in Hospitals? Perspectives of Those Involved in Managing Nosocomial SARS-CoV-2. medRxiv. 2022 doi: 10.1101/2022.06.15.22276423.
- Greenhalgh T, Jimenez JL, Prather KA, Tufekci Z, Fisman D, Schooley R. Ten scientific reasons in support of airborne transmission of SARS-cov-2. Lancet. 2021;397:1603–1605. doi: 10.1016/S0140-6736(21)00869-2.
- Houldcroft CJ, Roy S, Morfopoulou S, Margetts BK, Depledge DP, Cudini J, Shah D, Brown JR, Romero EY, Williams R, Cloutman-Green E, Rao K, Standing JF, Hartley JC, Breuer J. Use of whole-genome sequencing of adenovirus in immunocompromised pediatric patients to identify nosocomial transmission and mixed-genotype infection. The Journal of Infectious Diseases. 2018;218:1261–1271. doi: 10.1093/infdis/jiy323.
- Illingworth CJR, Hamilton WL, Jackson C, Warne B, Popay A, Meredith L, Hosmillo M, Jahun A, Fieldman T, Routledge M, Houldcroft CJ, Caller L, Caddy S, Yakovleva A, Hall G, Khokhar FA, Feltwell T, Pinckert ML, Georgana I, Chaudhry Y, Curran M, Parmar S, Sparkes D, Rivett L, Jones NK, Sridhar S, Forrest S, Dymond T, Grainger K, Workman C, Gkrania-Klotsas E, Brown NM, Weekes MP, Baker S, Peacock SJ, Gouliouris T, Goodfellow I, Angelis DD, Török ME. A2B-COVID: a tool for rapidly evaluating potential SARS-cov-2 transmission events. Molecular Biology and Evolution. 2022;39:msac025. doi: 10.1093/molbev/msac025.
- Kahan BC, Rushton H, Morris TP, Daniel RM. A comparison of methods to adjust for continuous covariates in the analysis of randomised trials. BMC Medical Research Methodology. 2016;16:42. doi: 10.1186/s12874-016-0141-3.
- Li P, Redden DT. Comparing denominator degrees of freedom approximations for the generalized linear mixed model in analyzing binary outcome in small sample cluster-randomized trials. BMC Medical Research Methodology. 2015;15:38. doi: 10.1186/s12874-015-0026-x.
- Li KK, Woo YM, Stirrup O, Hughes J, Ho A, Filipe ADS, Johnson N, Smollett K, Mair D, Carmichael S, Tong L, Nichols J, Aranday-Cortes E, Brunker K, Parr YA, Nomikou K, McDonald SE, Niebel M, Asamaphan P, Sreenu VB, Robertson DL, Taggart A, Jesudason N, Shah R, Shepherd J, Singer J, Taylor AHM, Cousland Z, Price J, Lees JS, Jones TPW, Lopez CV, MacLean A, Starinskij I, Gunson R, Morris STW, Thomson PC, Geddes CC, Traynor JP, Breuer J, Thomson EC, Mark PB, COVID-19 Genomics UK consortium Genetic epidemiology of SARS-cov-2 transmission in renal dialysis units-a high risk community-hospital interface. The Journal of Infection. 2021;83:96–103. doi: 10.1016/j.jinf.2021.04.020.
- Lindsey BB, Villabona-Arenas CJ, Campbell F, Keeley AJ, Parker MD, Shah DR, Parsons H, Zhang P, Kakkar N, Gallis M, Foulkes BH, Wolverson P, Louka SF, Christou S, State A, Johnson K, Raza M, Hsu S, Jombart T, Cori A, Evans CM, Partridge DG, Atkins KE, Hué S, de Silva TI, Sheffield COVID-19 Genomics Group. COVID-19 Genomics UK consortium. CMMID COVID-19 working group Characterising within-hospital sars-cov-2 transmission events using epidemiological and viral genomic data across two pandemic waves. Nature Communications. 2022;13:671. doi: 10.1038/s41467-022-28291-y.
- Lucey M, Macori G, Mullane N, Sutton-Fitzpatrick U, Gonzalez G, Coughlan S, Purcell A, Fenelon L, Fanning S, Schaffer K. Whole-Genome sequencing to track severe acute respiratory syndrome coronavirus 2 (SARS-cov-2) transmission in nosocomial outbreaks. Clinical Infectious Diseases. 2021;72:e727–e735. doi: 10.1093/cid/ciaa1433.
- Lumley SF, Constantinides B, Sanderson N, Rodger G, Street TL, Swann J, Chau KK, O’Donnell D, Warren F, Hoosdally S, O’Donnell A-M, Walker TM, Stoesser NE, Butcher L, Peto TE, Crook DW, Jeffery K, Matthews PC, Eyre DW, OUH Microbiology laboratory. OUH Infection Prevention and Control team Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-cov-2 is underestimated and mostly mediated by a small number of highly infectious individuals. The Journal of Infection. 2021;83:473–482. doi: 10.1016/j.jinf.2021.07.034.
- Meredith LW, Hamilton WL, Warne B, Houldcroft CJ, Hosmillo M, Jahun AS, Curran MD, Parmar S, Caller LG, Caddy SL, Khokhar FA, Yakovleva A, Hall G, Feltwell T, Forrest S, Sridhar S, Weekes MP, Baker S, Brown N, Moore E, Popay A, Roddick I, Reacher M, Gouliouris T, Peacock SJ, Dougan G, Török ME, Goodfellow I. Rapid implementation of SARS-cov-2 sequencing to investigate cases of health-care associated COVID-19: a prospective genomic surveillance study. The Lancet Infectious Diseases. 2020;20:1263–1272. doi: 10.1016/S1473-3099(20)30562-4.
- Mishra S, Mindermann S, Sharma M, Whittaker C, Mellan TA, Wilton T, Klapsa D, Mate R, Fritzsche M, Zambon M, Ahuja J, Howes A, Miscouridou X, Nason GP, Ratmann O, Semenova E, Leech G, Sandkühler JF, Rogers-Smith C, Vollmer M, Unwin HJT, Gal Y, Chand M, Gandy A, Martin J, Volz E, Ferguson NM, Bhatt S, Brauner JM, Flaxman S, COVID-19 Genomics UK Consortium Changing composition of SARS-cov-2 lineages and rise of delta variant in England. EClinicalMedicine. 2021;39:101064. doi: 10.1016/j.eclinm.2021.101064.
- Mitchell BG, Fasugba O, Russo PL. Where is the strength of evidence? A review of infection prevention and control guidelines. The Journal of Hospital Infection. 2020;105:242–251. doi: 10.1016/j.jhin.2020.01.008.
- O’Hara LM, Blanco N, Leekha S, Stafford KA, Slobogean GP, Ludeman E, Harris AD, CDC Prevention Epicenters Program Design, implementation, and analysis considerations for cluster-randomized trials in infection control and hospital epidemiology: a systematic review. Infection Control and Hospital Epidemiology. 2019;40:686–692. doi: 10.1017/ice.2019.48.
- Oliver D. David oliver: could we do better on hospital acquired covid-19 in a future wave? BMJ. 2021a;372:70. doi: 10.1136/bmj.n70.
- Oliver D. David oliver: deaths from hospital acquired covid are everyone’s problem. BMJ. 2021b;373:1492. doi: 10.1136/bmj.n1492.
- Oude Munnink BB, Worp N, Nieuwenhuijse DF, Sikkema RS, Haagmans B, Fouchier RAM, Koopmans M. The next phase of SARS-cov-2 surveillance: real-time molecular epidemiology. Nature Medicine. 2021;27:1518–1524. doi: 10.1038/s41591-021-01472-w.
- Ponsford MJ, Ward TJC, Stoneham SM, Dallimore CM, Sham D, Osman K, Barry SM, Jolles S, Humphreys IR, Farewell D. A systematic review and meta-analysis of inpatient mortality associated with nosocomial and community COVID-19 exposes the vulnerability of immunosuppressed adults. Frontiers in Immunology. 2021;12:744696. doi: 10.3389/fimmu.2021.744696.
- Public Health England COVID-19: epidemiological definitions of outbreaks and clusters in particular settings. 2020. [August 7, 2020].
- Read JM, Green CA, Harrison EM, Docherty AB, Funk S, Harrison J, Girvan M, Hardwick HE, Turtle L, Dunning J, Nguyen-Van-Tam JS, Openshaw PJ, Baillie JK, Semple MG, ISARIC4C investigators Hospital-acquired SARS-cov-2 infection in the UK’s first COVID-19 pandemic wave. Lancet. 2021;398:1037–1038. doi: 10.1016/S0140-6736(21)01786-4.
- Roy S, Hartley J, Dunn H, Williams R, Williams CA, Breuer J. Whole-Genome sequencing provides data for stratifying infection prevention and control management of nosocomial influenza A. Clinical Infectious Diseases. 2019;69:1649–1656. doi: 10.1093/cid/ciz020.
- Snell LB, Awan AR, Charalampous T, Alcolea-Medina A, Douthwaite ST, Edgeworth JD, Nebbia G. SARS-cov-2 variants with shortened incubation periods necessitate new definitions for nosocomial acquisition. The Journal of Infection. 2022a;84:248–288. doi: 10.1016/j.jinf.2021.08.041.
- Snell LB, Fisher CL, Taj U, Stirrup O, Merrick B, Alcolea-Medina A, Charalampous T, Signell AW, Wilson HD, Betancor G, Kia Ik MT, Cunningham E, Cliff PR, Pickering S, Galao RP, Batra R, Neil SJD, Malim MH, Doores KJ, Douthwaite ST, Nebbia G, Edgeworth JD, Awan AR, COVID-19 Genomics UK consortium Combined epidemiological and genomic analysis of nosocomial SARS-cov-2 infection early in the pandemic and the role of unidentified cases in transmission. Clinical Microbiology and Infection. 2022b;28:93–100. doi: 10.1016/j.cmi.2021.07.040.
- Stirrup O, Hughes J, Parker M, Partridge DG, Shepherd JG, Blackstone J. Rapid feedback on hospital onset SARS-cov-2 infections combining epidemiological and sequencing data. eLife. 2021;10:e65828. doi: 10.7554/eLife.65828.
- The COVID-19 Genomics UK consortium An integrated national scale SARS-cov-2 genomic surveillance network. The Lancet Microbe. 2020;1:e99–e100. doi: 10.1016/S2666-5247(20)30054-9.
- Thompson JA, Hemming K, Forbes A, Fielding K, Hayes R. Comparison of small-sample standard-error corrections for generalised estimating equations in stepped wedge cluster randomised trials with a binary outcome: a simulation study. Statistical Methods in Medical Research. 2021;30:425–439. doi: 10.1177/0962280220958735.
- Volz E, Mishra S, Chand M, Barrett JC, Johnson R, Geidelberg L, Hinsley WR, Laydon DJ, Dabrera G, O’Toole Á, Amato R, Ragonnet-Cronin M, Harrison I, Jackson B, Ariani CV, Boyd O, Loman NJ, McCrone JT, Gonçalves S, Jorgensen D, Myers R, Hill V, Jackson DK, Gaythorpe K, Groves N, Sillitoe J, Kwiatkowski DP, Flaxman S, Ratmann O, Bhatt S, Hopkins S, Gandy A, Rambaut A, Ferguson NM, COVID-19 Genomics UK consortium Assessing transmissibility of SARS-cov-2 lineage B.1.1.7 in England. Nature. 2021;593:266–269. doi: 10.1038/s41586-021-03470-x.
Source: PubMed